{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:48:15Z","timestamp":1785739695117,"version":"3.56.0"},"reference-count":101,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centre de recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont"},{"id":[{"id":"https:\/\/ror.org\/03rdc4968","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Primary hyperparathyroidism (PHPT) and vitamin D deficiency (VD) are two frequent medical conditions in the Western world. Purely by dint of their prevalence, these conditions are commonly comorbid. Moreover, they can interact with one another: VD may stimulate PTH secretion, while PHPT may lead to unregulated vitamin D activation from 25-hydroxyvitamin D (25OHD) to 1,25-dihydroxyvitamin D (1,25OH2D), thereby lowering 25OHD levels and further exacerbating VD. Thus, a real conundrum arises: should the careful clinician replete VD in PHPT or not? On the one hand, both conditions could lead to bone mineral density (BMD) loss if untreated, ultimately resulting in osteoporosis and fragility fractures; on the other hand, vitamin D supplementation could lead to further worsening of hypercalcemia and its dreaded complications. To complicate matters, patients undergoing parathyroidectomy (PTX) after long-standing PHPT can also suffer from postoperative hungry-bone syndrome and symptomatic hypocalcemia, which may be further exacerbated by VD. This narrative review aims to summarize the relevant pathophysiological mechanisms underlying these two diseases and their complex interactions. The latest evidence regarding thresholds and targets for vitamin D supplementation in PHPT will be discussed, with a focus on the balance between benefits and risks.<\/jats:p>","DOI":"10.3390\/nu18152504","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:17:40Z","timestamp":1785737860000},"page":"2504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7346-7730","authenticated-orcid":false,"given":"Thomas","family":"Audet","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0C1, Canada"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9e","family":"B\u00e9gin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0C1, Canada"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Brossard","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0C1, Canada"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Georges","family":"Ste-Marie","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0C1, Canada"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Philippe","family":"Laurin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Division of Nephrology, H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Centre de Recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Centre de Recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Division of Endocrinology, H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Hoang Lan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Centre de Recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Division of Endocrinology, H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Dupuis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"},{"name":"Division of Nephrology, H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Centre de Recherche de l\u2019H\u00f4pital Maisonneuve-Rosemont, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism (2003). Asymptomatic primary hyperparathyroidism: Standards and guidelines for diagnosis and management in Canada: Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism position paper. Endocr. Pract., 9, 400\u2013405.","DOI":"10.4158\/EP.9.5.400"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cen.12569","article-title":"Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers","volume":"82","author":"Berger","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jamcollsurg.2011.06.401","article-title":"Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?","volume":"213","author":"Bargren","year":"2011","journal-title":"J. Am. Coll. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1017\/S1355617709990695","article-title":"Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy","volume":"15","author":"Benge","year":"2009","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07435800.2018.1431275","article-title":"Occult urolithiasis in asymptomatic primary hyperparathyroidism","volume":"43","author":"Tay","year":"2018","journal-title":"Endocr. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jbspin.2004.08.015","article-title":"Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus","volume":"73","author":"Chappard","year":"2006","journal-title":"Jt. Bone Spine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/jc.2018-02483","article-title":"Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism","volume":"104","author":"Reid","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1017\/S0007114521005080","article-title":"Influence of geographical latitude on vitamin D status: Cross-sectional results from the BiomarCaRE consortium","volume":"128","author":"Oskarsson","year":"2022","journal-title":"Br. J. Nutr."},{"key":"ref_12","unstructured":"Canada, S. (2025, September 29). Table: 13-10-0872-01 Vitamin D Status of Canadians, Combined Cycles, by Age Group and Sex. Available online: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310087201."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cen.12210","article-title":"Vitamin D status in primary hyperparathyroidism: A Southern European perspective","volume":"79","author":"Tassone","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.ajkd.2023.04.017","article-title":"Calcium and Phosphate Disorders: Core Curriculum 2024","volume":"83","author":"Murray","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","unstructured":"Bilezikian, J.P., and The American Society for Bone and Mineral Research (2025). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, LWW."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41581-022-00665-x","article-title":"Regulation of FGF23 production and phosphate metabolism by bone\u2013kidney interactions","volume":"19","author":"Agoro","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_18","unstructured":"Khan, M., Jose, A., and Sharma, S. (2025). Physiology, Parathyroid Hormone. StatPearls, StatPearls Publishing LLC."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Stack, B.C., Singer, M.C., and Shonka, D.C. (2025). Medical and Surgical Treatment of Parathyroid Diseases: An Evidence-Based Approach, Springer.","DOI":"10.1007\/978-3-031-81813-4"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global Consensus Recommendations on Prevention and Management of Nutritional Rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105616","DOI":"10.1016\/j.jsbmb.2020.105616","article-title":"Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism","volume":"199","author":"Meng","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40618-021-01633-1","article-title":"Total and free vitamin D metabolites in patients with primary hyperparathyroidism","volume":"45","author":"Meng","year":"2022","journal-title":"J. Endocrinol. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eprac.2024.10.005","article-title":"Parathyroidectomy Reduces Inflammatory Cytokines and Increases Vitamin D Metabolites in Patients With Primary Hyperparathyroidism","volume":"31","author":"Meng","year":"2025","journal-title":"Endocr. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4158\/EP12371.OR","article-title":"Vitamin D-binding protein levels in female patients with primary hyperparathyroidism","volume":"19","author":"Wang","year":"2013","journal-title":"Endocr. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4158\/EP161434.OR","article-title":"Free and Bioavailable 25-Hydroxyvitamin D Levels in Patients with Primary Hyperparathyroidism","volume":"23","author":"Wang","year":"2017","journal-title":"Endocr. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, X., Sheng, Z., Meng, L., Su, C., Trooskin, S., and Shapses, S.A. (2019). 25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00171"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4158\/EP161604.RA","article-title":"Vitamin D Binding Protein and 25-Hydroxyvitamin D Levels: Emerging Clinical Applications","volume":"23","author":"Jassil","year":"2017","journal-title":"Endocr. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bouillon, R., Schuit, F., Antonio, L., and Rastinejad, F. (2019). Vitamin D Binding Protein: A Historic Overview. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00910"},{"key":"ref_29","first-page":"183","article-title":"Levels of bioavailable, and free forms of 25(OH)D after supplementation with vitamin D(3) in primary hyperparathyroidism","volume":"80","author":"Ohe","year":"2023","journal-title":"Endocrine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-016-0974-x","article-title":"Vitamin D status in primary hyperparathyroidism: Effect of genetic background","volume":"55","author":"Battista","year":"2017","journal-title":"Endocrine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02680.x","article-title":"Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function","volume":"66","author":"Moosgaard","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kabadi, U.M. (2020). Low 25-Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25-Hydroxyvitamin D May Not Be \u201cTrue\u201d Deficiency. JBMR Plus, 4.","DOI":"10.1002\/jbm4.10415"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00268-002-6433-2","article-title":"Multifactorial risk profile for bone fractures in primary hyperparathyroidism","volume":"26","author":"Westerdahl","year":"2002","journal-title":"World J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs0730659","article-title":"Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism","volume":"73","author":"Clements","year":"1987","journal-title":"Clin. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/07853898909149207","article-title":"Serum vitamin D metabolite concentrations in primary hyperparathyroidism","volume":"21","author":"Saaristo","year":"1989","journal-title":"Ann. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-025-04173-3","article-title":"Phosphate metabolism in primary hyperparathyroidism: A real-life long-term study","volume":"88","author":"Columbu","year":"2025","journal-title":"Endocrine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-11-0523","article-title":"Increased circulating levels of FGF23: An adaptive response in primary hyperparathyroidism?","volume":"166","author":"Witteveen","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/IJGM.S253246","article-title":"Evaluation of Serum Level of FGF23 and 1,25(OH)(2)D(3) in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy","volume":"13","author":"Hassani","year":"2020","journal-title":"Int. J. Gen. Med."},{"key":"ref_41","unstructured":"Ross, A.C., Taylor, C.L., Yaktine, A.L., and Del Valle, H.B. (2011). The National Academies Collection: Reports funded by National Institutes of Health. Dietary Reference Intakes for Calcium and Vitamin D, National Academies Press."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s00198-015-3199-6","article-title":"Low vitamin D levels have become less common in primary hyperparathyroidism","volume":"26","author":"Walker","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The Efficacy and Safety of Medical and Surgical Therapy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"37","author":"Ye","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.23736\/S0391-1977.17.02584-6","article-title":"Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: A systematic review and meta-analysis","volume":"44","author":"Loh","year":"2019","journal-title":"Minerva Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40618-020-01473-5","article-title":"Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: A systematic review and meta-analysis","volume":"44","author":"Song","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: A meta-analysis and review of literature","volume":"80","author":"Shah","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: A randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM198510313131804","article-title":"Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism","volume":"313","author":"LoCascio","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_49","first-page":"3541","article-title":"Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism","volume":"85","author":"Kantorovich","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.surg.2008.06.032","article-title":"Preoperative vitamin D replacement therapy in primary hyperparathyroidism: Safe and beneficial?","volume":"144","author":"Grubbs","year":"2008","journal-title":"Surgery"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-10-1053","article-title":"Different vitamin D substrate-product relationship after oral vitamin D supplementation in familial benign hypercalcemia, primary hyperparathyroidism, and healthy controls","volume":"164","author":"Bevilacqua","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_55","first-page":"e120","article-title":"Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: Aggravating the osseous attack","volume":"40","author":"Foucan","year":"2011","journal-title":"Presse Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EC-12-0008","article-title":"Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism","volume":"1","author":"Rao","year":"2012","journal-title":"Endocr. Connect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4158\/EP12155.OR","article-title":"Safety of vitamin D replacement in patients with primary hyperparathyroidism and concomitant vitamin D deficiency","volume":"19","author":"Wagner","year":"2013","journal-title":"Endocr. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40618-014-0056-y","article-title":"Management of hypovitaminosis D in patients with primary hyperparathyroidism","volume":"37","author":"Rathi","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/0004563214564400","article-title":"Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency","volume":"52","author":"Das","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcx200","article-title":"The impact of vitamin D status and parameters of calcium metabolism in patients with primary hyperparathyroidism","volume":"111","author":"Jaffe","year":"2018","journal-title":"QJM"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-63-1-246","article-title":"Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism","volume":"63","author":"Netelenbos","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_62","first-page":"250","article-title":"Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism","volume":"120","author":"Lind","year":"1989","journal-title":"Acta Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00365599109107953","article-title":"Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals","volume":"25","author":"Lind","year":"1991","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_64","unstructured":"Columbia University (2026, July 13). Vitamin D Repletion in Primary Hyperparathyroidism. ClinicalTrials.gov Identifier: NCT01306656. Updated [16.04.2019], Available online: https:\/\/clinicaltrials.gov\/study\/NCT01306656."},{"key":"ref_65","unstructured":"Columbia University (2026, July 13). Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D. ClinicalTrials.gov Identifier: NCT01329666. Updated [05.03.2015], Available online: https:\/\/clinicaltrials.gov\/study\/NCT01329666."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","article-title":"PROSPERO: An International Register of Systematic Review Protocols","volume":"38","author":"Schiavo","year":"2019","journal-title":"Med. Ref. Serv. Q."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-14-0940","article-title":"No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: Results from a randomized controlled trial","volume":"172","author":"Rolighed","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-14-0757","article-title":"Health-related quality of life after successful surgery for primary hyperparathyroidism: No additive effect from vitamin D supplementation: Results of a double-blind randomized study","volume":"172","author":"Norenstedt","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_70","unstructured":"Chandler, J., Cumpston, M., Higgins, J.P.T., Li, T., Page, M.J., Thomas, J., Welch, V.A., and Cochrane, C. (2019). Cochrane Handbook for Systematic Reviews of Interventions, Wiley-Blackwell. [2nd ed.]."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.1987.125","article-title":"Renal mass and reserve of vitamin D: Determinants in primary hyperparathyroidism","volume":"31","author":"Patron","year":"1987","journal-title":"Kidney Int."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Christensen, M.H., Apalset, E.M., Nordb\u00f8, Y., Varhaug, J.E., Mellgren, G., and Lien, E.A. (2013). 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056019"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1507\/endocrj.K07-102","article-title":"Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism","volume":"55","author":"Inoue","year":"2008","journal-title":"Endocr. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00198-017-3918-2","article-title":"Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism","volume":"28","author":"Lee","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1507\/endocrj.45.123","article-title":"Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism","volume":"45","author":"Kobayashi","year":"1998","journal-title":"Endocr. J."},{"key":"ref_77","first-page":"56","article-title":"The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism","volume":"70","author":"Emral","year":"2023","journal-title":"Endocrinol. Diabetes Nutr. (Engl. Ed.)"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","article-title":"Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism","volume":"55","author":"Viccica","year":"2017","journal-title":"Endocrine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2004.01946.x","article-title":"Vitamin D status in female patients with primary hyperparathyroidism: Does it play a role in skeletal damage?","volume":"60","author":"Carnevale","year":"2004","journal-title":"Clin. Endocrinol."},{"key":"ref_80","first-page":"242","article-title":"Concentrations of total, bioavailable, and free 25OHD in individuals with and without primary hyperparathyroidism and their correlations to DXA and trabecular bone score","volume":"67","author":"Santos","year":"2023","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00003086-198803000-00004","article-title":"Osteomalacia as a very late manifestation of primary hyperparathyroidism","volume":"228","author":"Kaplan","year":"1988","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_83","first-page":"2031","article-title":"Osteomalacia with biochemical syndrome of hyperparathyroidism or primary hyperparathyroidism with clinical syndrome of osteomalacia","volume":"64","author":"Bordier","year":"1956","journal-title":"Presse Med. (1893)"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2015-4218","article-title":"Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism","volume":"101","author":"Walker","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"101435","DOI":"10.1016\/j.jocd.2023.101435","article-title":"Executive Summary of the 2023 Adult Position Development Conference of the International Society for Clinical Densitometry: DXA Reporting, Follow-up BMD Testing and Trabecular Bone Score Application and Reporting","volume":"27","author":"Shuhart","year":"2024","journal-title":"J. Clin. Densitom. Off. J. Int. Soc. Clin. Densitom."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in Medical Inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s40618-023-02057-9","article-title":"Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: Data mining for relationship between vitamin D and parathyroid hormone","volume":"46","author":"Gong","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjmed.2011.07.009","article-title":"The relationship between serum 25(OH)D and parathyroid hormone levels","volume":"124","author":"Saliba","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.328","article-title":"Why the IOM recommendations for vitamin D are deficient","volume":"26","author":"Heaney","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","article-title":"Vitamin D physiology","volume":"92","author":"Lips","year":"2006","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Mendes, M.M., Hart, K.H., Lanham-New, S.A., and Botelho, P.B. (2020). Suppression of Parathyroid Hormone as a Proxy for Optimal Vitamin D Status: Further Analysis of Two Parallel Studies in Opposite Latitudes. Nutrients, 12.","DOI":"10.3390\/nu12040942"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials","volume":"293","author":"Willett","year":"2005","journal-title":"JAMA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Willett","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jbmr.2102","article-title":"Vitamin D supplementation after parathyroidectomy: Effect on bone mineral density-a randomized double-blind study","volume":"29","author":"Norenstedt","year":"2014","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Castellano, E., and Saponaro, F. (2025). Vitamin D Metabolism and the Risk of Renal Stones: A Focus on PHPT. Metabolites, 15.","DOI":"10.3390\/metabo15100639"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1258\/acb.2010.010202","article-title":"Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency","volume":"48","author":"Jayasena","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: Still a challenge in the post-operative management of primary hyperparathyroidism: A systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1457496920962601","article-title":"Role of vitamin D supplements in prevention of hungry bone syndrome after successful parathyroidectomy for primary hyperparathyroidism: A prospective study","volume":"110","author":"Salman","year":"2021","journal-title":"Scand. J. Surg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary Hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1169249","DOI":"10.1155\/2023\/1169249","article-title":"Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review","volume":"2023","author":"Yedla","year":"2023","journal-title":"Int. J. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of Primary Hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:31:53Z","timestamp":1785738713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":101,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["nu18152504"],"URL":"https:\/\/doi.org\/10.3390\/nu18152504","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}